Protagonist Therapeutics, Inc
Protagonist is a late stage clinical company developing peptide candidates from our discovery platform. Our primary focus is on inflammation, hematology, and metabolic disease.
)
January 11-14, 2027 | San Francisco
January 11-14, 2027 | San Francisco
)
)
January 11-14, 2027 | San Francisco
){kind=logo}
){kind=logo}
)